PT  - JOURNAL ARTICLE
AU  - Sukumaran, Salil K.
AU  - Paul, Pradip
AU  - Guttal, Vishwesha
AU  - Holla, Bharath
AU  - Vemula, Alekhya
AU  - Bhatt, Harsimar
AU  - Bisht, Piyush
AU  - Mathew, Kezia
AU  - Nadella, Ravi K
AU  - Varghese, Anu Mary
AU  - Vijayalakshmi, K
AU  - Purushottam, Meera
AU  - Jain, Sanjeev
AU - ADBS Consortium
AU  - Sud, Reeteka
AU  - Viswanath, Biju
TI  - Dysregulation in EGF/ERBB signaling pathway may explain abnormalities of neural precursor migration in bipolar disorder
AID  - 10.1101/2021.04.22.21254208
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.22.21254208
4099  - http://medrxiv.org/content/early/2021/10/27/2021.04.22.21254208.short
4100  - http://medrxiv.org/content/early/2021/10/27/2021.04.22.21254208.full
AB  - Cellular migration is a ubiquitous feature that brings brain cells into appropriate spatial relationships over time; and is believed to contribute to the pathology of bipolar disorder (BD). There are also structural differences in BD-brain, demonstrated by multiple imaging studies. We studied the movement patterns of induced pluripotent stem cell (IPSC) derived neural precursor cell (NPC) derived from individuals with BD, in an effort to recapitulate and study anomalies in migration. These individual patients had a severe clinical phenotype, including anomalies in structural brain imaging. We conducted time-lapse analysis and identified abnormal directionality of cellular migration in NPCs derived from these patients. We further studied the whole exome, and NPC transcriptomes of these patients, to investigate the underlying mechanisms of aberrant migration. Whole exome sequencing revealed several rare and deleterious variants in migration-related genes. Transcriptomic analysis showed downregulation of genes that were part of the EGF/ERBB signaling pathway. We suggest that collective, systemic dysregulation may produce the aberrant cellular phenotype; which could contribute to the functional and structural changes in the brain, reported in bipolar disorder.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a grant from the Department of Biotechnology (COE), India funded grants- Targeted generation and interrogation of cellular models and networks in neuro-psychiatric disorders using candidate genes (BT/01/CEIB/11/VI/11/2012) and Accelerating program for discovery in brain disorders using stem cells (BT/PR17316/MED/31/326/2015) (ADBS); the Department of Science and Technology, India funded grants- Imaging-genomics approach to identify molecular markers of Lithium response in Bipolar disorder through the DST-INSPIRE Faculty Fellowship awarded to Dr. Biju Viswanath (Project number 00671, Code: IFA-12-LSBM-44) and SCIENCE& ENGINEERING RESEARCH BOARD (SERB) project Dissecting the biology of lithium response in human induced pluripotent stem cell derived neurons from patients with bipolar affective disorder (FILE NO. ECR/2016/002076).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol has been approved by the ethics committee of the National Institute of Mental Health and Neurosciences, Bengaluru, India (No. NIMHANS/DO/96TH lEC/2015). Clinical protocol for this study conforms to the ethical norms and standards in the Declaration of Helsinki. Committee decision: protocol approved Committee members: 1. Dr. AK Kurpad, Professor of Physiology, NIMHANS; Chair, Ethics committee 2. Mr. AR Patil, Professor, National Law School of India; legal expert on the Ethics committee 3. Dr. Dennis Xavier, Prof. & Head, Dept of Pharmacology, St. John's Medical College 4. Dr. Rajaram Subbian, social scientist on the ethics committee 5. Dr. Pratima Murthy, Dept. of Psychiatry, NIMHANS 6. Dr. Pramod Pal, Dept. of Neurology, NIMHANS 7. Dr. M. Jayaram, Dept of Speech Pathology & Audiology 8. Dr. V. Ravi, Dept. of Neurovirology, NIMHANS 9. Dr. B.N. Gangadhar, Dept. of Psychiatry, NIMHANSI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAvailable upon request